Free Trial

Metagenomi (MGX) Earnings Date, Estimates & Call Transcripts

Metagenomi logo
$1.65 -0.04 (-2.37%)
(As of 11/20/2024 ET)

Metagenomi Latest Earnings Summary

Latest Q2 2024
Earnings Date
Aug. 14Estimated
Actual EPS
(Aug. 14)
-$0.29 Beat By $0.30
Consensus EPS
(Aug. 14)
-$0.59

Metagenomi issued Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.29, which beat analysts' consensus estimates of -$0.59 by $0.30. Quarterly revenue was reported to be $20.01 million, above analyst estimates of $14.80 million. With a trailing EPS of $0.00, Metagenomi's earnings are expected to grow next year, from ($2.73) to ($2.68) per share.

Get Metagenomi Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Metagenomi and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

MGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Metagenomi Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$1.20-$1.20-$1.20
Q2 20241-$0.69-$0.69-$0.69
Q3 20241-$0.68-$0.68-$0.68
Q4 20241-$0.69-$0.69-$0.69
FY 20244-$3.26-$3.26-$3.26
Q1 20251-$0.71-$0.71-$0.71
Q2 20251-$0.73-$0.73-$0.73
Q3 20251-$0.74-$0.74-$0.74
Q4 20251-$0.76-$0.76-$0.76
FY 20254($2.94)($2.94)($2.94)

Metagenomi Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/14/2024Q2 2024-$0.59-$0.29+$0.30-$0.29$14.80M$20.01M
5/14/2024Q1 2024-$0.95-$1.19 -$0.24-$1.19$8.30M$11.16M  

Metagenomi Earnings - Frequently Asked Questions

Metagenomi (NASDAQ:MGX) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on MGX's earnings history.

In the previous quarter, Metagenomi (NASDAQ:MGX) reported ($0.29) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.59) by $0.30. Learn more on analysts' earnings estimate vs. MGX's actual earnings.

Metagenomi (NASDAQ:MGX) has a recorded annual revenue of $55.08 million.

Metagenomi (NASDAQ:MGX) has a recorded net income of -$68.25 million. MGX has generated $0.00 earnings per share over the last four quarters.

Metagenomi's earnings are expected to grow from ($2.83) per share to ($2.74) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:MGX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners